Chapter/Section Purchase

1 Study Coverage
1.1 Axillary Hyperhidrosis Drug Product Introduction
1.2 Market by Type
1.2.1 Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Botulinum ToxinA
1.2.3 Glycopyrrolate
1.2.4 Glycopyrronium Tosylate
1.2.5 Others
1.3 Market by Application
1.3.1 Global Axillary Hyperhidrosis Drug Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Clinic
1.3.3 Hospital
1.3.4 Home Care
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Axillary Hyperhidrosis Drug Sales Estimates and Forecasts 2017-2028
2.2 Global Axillary Hyperhidrosis Drug Revenue Estimates and Forecasts 2017-2028
2.3 Global Axillary Hyperhidrosis Drug Revenue by Region: 2017 VS 2021 VS 2028
2.4 Global Axillary Hyperhidrosis Drug Sales by Region
2.4.1 Global Axillary Hyperhidrosis Drug Sales by Region (2017-2022)
2.4.2 Global Sales Axillary Hyperhidrosis Drug by Region (2023-2028)
2.5 Global Axillary Hyperhidrosis Drug Revenue by Region
2.5.1 Global Axillary Hyperhidrosis Drug Revenue by Region (2017-2022)
2.5.2 Global Axillary Hyperhidrosis Drug Revenue by Region (2023-2028)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Axillary Hyperhidrosis Drug Sales by Manufacturers
3.1.1 Global Top Axillary Hyperhidrosis Drug Manufacturers by Sales (2017-2022)
3.1.2 Global Axillary Hyperhidrosis Drug Sales Market Share by Manufacturers (2017-2022)
3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Axillary Hyperhidrosis Drug in 2021
3.2 Global Axillary Hyperhidrosis Drug Revenue by Manufacturers
3.2.1 Global Axillary Hyperhidrosis Drug Revenue by Manufacturers (2017-2022)
3.2.2 Global Axillary Hyperhidrosis Drug Revenue Market Share by Manufacturers (2017-2022)
3.2.3 Global Top 10 and Top 5 Companies by Axillary Hyperhidrosis Drug Revenue in 2021
3.3 Global Axillary Hyperhidrosis Drug Sales Price by Manufacturers (2017-2022)
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Axillary Hyperhidrosis Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Axillary Hyperhidrosis Drug Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
4.1 Global Axillary Hyperhidrosis Drug Sales by Type
4.1.1 Global Axillary Hyperhidrosis Drug Historical Sales by Type (2017-2022)
4.1.2 Global Axillary Hyperhidrosis Drug Forecasted Sales by Type (2023-2028)
4.1.3 Global Axillary Hyperhidrosis Drug Sales Market Share by Type (2017-2028)
4.2 Global Axillary Hyperhidrosis Drug Revenue by Type
4.2.1 Global Axillary Hyperhidrosis Drug Historical Revenue by Type (2017-2022)
4.2.2 Global Axillary Hyperhidrosis Drug Forecasted Revenue by Type (2023-2028)
4.2.3 Global Axillary Hyperhidrosis Drug Revenue Market Share by Type (2017-2028)
4.3 Global Axillary Hyperhidrosis Drug Price by Type
4.3.1 Global Axillary Hyperhidrosis Drug Price by Type (2017-2022)
4.3.2 Global Axillary Hyperhidrosis Drug Price Forecast by Type (2023-2028)
5 Market Size by Application
5.1 Global Axillary Hyperhidrosis Drug Sales by Application
5.1.1 Global Axillary Hyperhidrosis Drug Historical Sales by Application (2017-2022)
5.1.2 Global Axillary Hyperhidrosis Drug Forecasted Sales by Application (2023-2028)
5.1.3 Global Axillary Hyperhidrosis Drug Sales Market Share by Application (2017-2028)
5.2 Global Axillary Hyperhidrosis Drug Revenue by Application
5.2.1 Global Axillary Hyperhidrosis Drug Historical Revenue by Application (2017-2022)
5.2.2 Global Axillary Hyperhidrosis Drug Forecasted Revenue by Application (2023-2028)
5.2.3 Global Axillary Hyperhidrosis Drug Revenue Market Share by Application (2017-2028)
5.3 Global Axillary Hyperhidrosis Drug Price by Application
5.3.1 Global Axillary Hyperhidrosis Drug Price by Application (2017-2022)
5.3.2 Global Axillary Hyperhidrosis Drug Price Forecast by Application (2023-2028)
6 North America
6.1 North America Axillary Hyperhidrosis Drug Market Size by Type
6.1.1 North America Axillary Hyperhidrosis Drug Sales by Type (2017-2028)
6.1.2 North America Axillary Hyperhidrosis Drug Revenue by Type (2017-2028)
6.2 North America Axillary Hyperhidrosis Drug Market Size by Application
6.2.1 North America Axillary Hyperhidrosis Drug Sales by Application (2017-2028)
6.2.2 North America Axillary Hyperhidrosis Drug Revenue by Application (2017-2028)
6.3 North America Axillary Hyperhidrosis Drug Market Size by Country
6.3.1 North America Axillary Hyperhidrosis Drug Sales by Country (2017-2028)
6.3.2 North America Axillary Hyperhidrosis Drug Revenue by Country (2017-2028)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Axillary Hyperhidrosis Drug Market Size by Type
7.1.1 Europe Axillary Hyperhidrosis Drug Sales by Type (2017-2028)
7.1.2 Europe Axillary Hyperhidrosis Drug Revenue by Type (2017-2028)
7.2 Europe Axillary Hyperhidrosis Drug Market Size by Application
7.2.1 Europe Axillary Hyperhidrosis Drug Sales by Application (2017-2028)
7.2.2 Europe Axillary Hyperhidrosis Drug Revenue by Application (2017-2028)
7.3 Europe Axillary Hyperhidrosis Drug Market Size by Country
7.3.1 Europe Axillary Hyperhidrosis Drug Sales by Country (2017-2028)
7.3.2 Europe Axillary Hyperhidrosis Drug Revenue by Country (2017-2028)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Axillary Hyperhidrosis Drug Market Size by Type
8.1.1 Asia Pacific Axillary Hyperhidrosis Drug Sales by Type (2017-2028)
8.1.2 Asia Pacific Axillary Hyperhidrosis Drug Revenue by Type (2017-2028)
8.2 Asia Pacific Axillary Hyperhidrosis Drug Market Size by Application
8.2.1 Asia Pacific Axillary Hyperhidrosis Drug Sales by Application (2017-2028)
8.2.2 Asia Pacific Axillary Hyperhidrosis Drug Revenue by Application (2017-2028)
8.3 Asia Pacific Axillary Hyperhidrosis Drug Market Size by Region
8.3.1 Asia Pacific Axillary Hyperhidrosis Drug Sales by Region (2017-2028)
8.3.2 Asia Pacific Axillary Hyperhidrosis Drug Revenue by Region (2017-2028)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Axillary Hyperhidrosis Drug Market Size by Type
9.1.1 Latin America Axillary Hyperhidrosis Drug Sales by Type (2017-2028)
9.1.2 Latin America Axillary Hyperhidrosis Drug Revenue by Type (2017-2028)
9.2 Latin America Axillary Hyperhidrosis Drug Market Size by Application
9.2.1 Latin America Axillary Hyperhidrosis Drug Sales by Application (2017-2028)
9.2.2 Latin America Axillary Hyperhidrosis Drug Revenue by Application (2017-2028)
9.3 Latin America Axillary Hyperhidrosis Drug Market Size by Country
9.3.1 Latin America Axillary Hyperhidrosis Drug Sales by Country (2017-2028)
9.3.2 Latin America Axillary Hyperhidrosis Drug Revenue by Country (2017-2028)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
9.3.6 Colombia
10 Middle East and Africa
10.1 Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Type
10.1.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Type (2017-2028)
10.1.2 Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Type (2017-2028)
10.2 Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Application
10.2.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Application (2017-2028)
10.2.2 Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Application (2017-2028)
10.3 Middle East and Africa Axillary Hyperhidrosis Drug Market Size by Country
10.3.1 Middle East and Africa Axillary Hyperhidrosis Drug Sales by Country (2017-2028)
10.3.2 Middle East and Africa Axillary Hyperhidrosis Drug Revenue by Country (2017-2028)
10.3.3 Turkey
10.3.4 Saudi Arabia
11 Company Profiles
11.1 Allergan Plc
11.1.1 Allergan Plc Corporation Information
11.1.2 Allergan Plc Overview
11.1.3 Allergan Plc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.1.4 Allergan Plc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.1.5 Allergan Plc Recent Developments
11.2 Brickell Biotech Inc
11.2.1 Brickell Biotech Inc Corporation Information
11.2.2 Brickell Biotech Inc Overview
11.2.3 Brickell Biotech Inc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.2.4 Brickell Biotech Inc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.2.5 Brickell Biotech Inc Recent Developments
11.3 Dermira Inc
11.3.1 Dermira Inc Corporation Information
11.3.2 Dermira Inc Overview
11.3.3 Dermira Inc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.3.4 Dermira Inc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.3.5 Dermira Inc Recent Developments
11.4 Dr. August Wolff GmbH & Co KG Arzneimittle
11.4.1 Dr. August Wolff GmbH & Co KG Arzneimittle Corporation Information
11.4.2 Dr. August Wolff GmbH & Co KG Arzneimittle Overview
11.4.3 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.4.4 Dr. August Wolff GmbH & Co KG Arzneimittle Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.4.5 Dr. August Wolff GmbH & Co KG Arzneimittle Recent Developments
11.5 GlaxoSmithKline Plc
11.5.1 GlaxoSmithKline Plc Corporation Information
11.5.2 GlaxoSmithKline Plc Overview
11.5.3 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.5.4 GlaxoSmithKline Plc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.5.5 GlaxoSmithKline Plc Recent Developments
11.6 TheraVida Inc
11.6.1 TheraVida Inc Corporation Information
11.6.2 TheraVida Inc Overview
11.6.3 TheraVida Inc Axillary Hyperhidrosis Drug Sales, Price, Revenue and Gross Margin (2017-2022)
11.6.4 TheraVida Inc Axillary Hyperhidrosis Drug Product Model Numbers, Pictures, Descriptions and Specifications
11.6.5 TheraVida Inc Recent Developments
12 Industry Chain and Sales Channels Analysis
12.1 Axillary Hyperhidrosis Drug Industry Chain Analysis
12.2 Axillary Hyperhidrosis Drug Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Axillary Hyperhidrosis Drug Production Mode & Process
12.4 Axillary Hyperhidrosis Drug Sales and Marketing
12.4.1 Axillary Hyperhidrosis Drug Sales Channels
12.4.2 Axillary Hyperhidrosis Drug Distributors
12.5 Axillary Hyperhidrosis Drug Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Axillary Hyperhidrosis Drug Industry Trends
13.2 Axillary Hyperhidrosis Drug Market Drivers
13.3 Axillary Hyperhidrosis Drug Market Challenges
13.4 Axillary Hyperhidrosis Drug Market Restraints
14 Key Findings in The Global Axillary Hyperhidrosis Drug Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer